FDA PCAC Recommends Six Peptides for the 503A Bulks List: What Compounding Pharmacies Need to Know - Buchanan Ingersoll & Rooney PC
FDA PCAC recommends six peptides for inclusion in the 503A Bulks List, impacting compounding pharmacies' practices and compliance requirements.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 3, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Compounding pharmacies, including independent and retail chains. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed. Regulated niches like Pharmacy & Controlled Substances move faster than most operators can track by hand, which is why Aforeworn watches the official sources for you and flags every material change the moment it appears.
What changed
Six peptides are now recommended for the 503A Bulks List, which may affect compounding practices and inventory management.
Who it affects
Compounding pharmacies, including independent and retail chains.
What you must do
Review and potentially adjust compounding practices to include the newly recommended peptides.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- CVS to pay $70,000 to resolve allegations that it filled fake prescriptions - KTTN
- Michigan Lists Pain Drug Gabapentin As Controlled Substance - CBS News
- Michigan begins process to make new synthetic drug illegal - Coldwater Daily Reporter
- Georgia Begins Dispensing Medical Cannabis at Independent Pharmacies - Cannabis Business Times
- CVS, Cigna sue Arkansas to overturn new PBM law - Healthcare Dive